Erasca, Inc. Announces Executive Changes

Erasca announced the appointment of:
Brian Baker as the new senior vice president of finance.
Ebun Garner, J.D. as general counsel and corporate secretary.
Chandra Lovejoy as senior vice president of regulatory affairs, bringing 20 years of global drug development experience, ranging from pre-investigational new drug activities through NDA submission and post-approval.

Erasca’s mission is embedded in its name: To erase cancer. Energized by recent scientific discoveries in drugging various biological drivers of cancer, Erasca is advancing multiple programs that shut down key cancer pathways to solve oncology’s hardest problems. Founded in 2018 and headquartered in San Diego, Erasca has raised $300 million in financing from investors who share the company’s bold mission, including ARCH Venture Partners, City Hill Ventures, and Cormorant Asset Management. Erasca is a trademark of Erasca, Inc.